NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

全球呼吸系統介入市場:呼吸系統疾病的罹患率上升造成市場擴大

Global Market Study on Interventional Pulmonology: Rising Prevalence of Respiratory Diseases Augment Market Expansion

出版商 Persistence Market Research 商品編碼 1004426
出版日期 內容資訊 英文 270 Pages
商品交期: 2-3個工作天內
價格
全球呼吸系統介入市場:呼吸系統疾病的罹患率上升造成市場擴大 Global Market Study on Interventional Pulmonology: Rising Prevalence of Respiratory Diseases Augment Market Expansion
出版日期: 2021年03月01日內容資訊: 英文 270 Pages
簡介

本報告提供全球呼吸系統介入市場相關調查,市場概要,市場趨勢,成功因素,市場規模的變化與預測,各產品、適應症、終端用戶、地區、主要國家詳細趨勢,價格分析,新型冠狀病毒感染疾病(COVID-19)的影響,市場結構,競爭情形,主要企業的簡介等全面性資訊。

目錄

第1章 摘要整理

第2章 市場概要

第3章 主要市場趨勢

第4章 主要成功因素

  • 價值鏈分析
  • 法規方案
  • 器官狹窄、支氣管狹窄的手術:各地區
  • 呼吸系統介入手術的統計:各地區

第5章 市場背景

  • 宏觀經濟要素
    • 全球GDP成長預測
    • 全球醫療支出
  • 預測要素 - 相關性和影響力
    • 呼吸疾病盛行率的上升
    • 治療費
    • 支撐醫療的政府資金
  • 市場動態
    • 促進因素
    • 阻礙因素
    • 趨勢
    • 市場機會分析

第6章 新型冠狀病毒感染疾病(COVID-19)的危機

  • 目前COVID-19相關統計與預測的影響
  • 目前GDP預測與預測的影響
  • 與2008年的經濟分析比較的目前經濟預測
  • COVID-19及影響分析
    • 收益:各產品
    • 收益:各適應症
    • 收益:各終端用戶
    • 收益:各國
  • 產業預測
  • 經濟影響
  • 的未來的影響

第7章 全球介入呼吸系統市場分析與預測

  • 市場分析(過去)
  • 市場預測(現在、未來)
    • 與前一年同期比較成長趨勢分析

第8章 價格分析

  • 地區市場價格分析:各產品
  • 價格的明細
    • 廠商等級的價格
    • 分銷商等級的價格
  • 全球平均價格分析基準

第9章 全球介入呼吸系統市場分析與預測

  • 市場分析(過去)
  • 市場預測(現在、未來)
    • 與前一年同期比較成長趨勢分析

第10章 全球介入呼吸系統市場分析與預測:各產品

  • 簡介、主要調查結果
  • 市場分析:各產品(過去)
  • 市場分析:各產品(現在、未來)
    • 電磁導航支氣管鏡檢驗(ENB)
    • IP診斷設備
    • IP治療設備
  • 市場魅力分析: 各產品

第11章 全球介入呼吸系統市場分析與預測:各適應症

  • 簡介、主要調查結果
  • 市場分析:各適應症(過去)
  • 市場分析:各適應症(現在、未來)
    • 氣喘
    • 肺癌症
    • COPD(慢性阻塞性肺病)
    • 異物取出
    • 氣管狹窄、支氣管狹窄
  • 市場魅力分析:各適應症

第12章 全球介入呼吸系統市場:各終端用戶

  • 簡介、主要調查結果
  • 市場分析:各終端用戶(過去)
  • 市場分析:各終端用戶(現在、未來)
    • 醫院
    • 呼吸系統內科
    • 門診病人手術中心
    • 診斷中心
  • 市場魅力分析: 各終端用戶

第13章 全球介入呼吸系統市場:各地區

  • 簡介
  • 市場分析:各市場區隔(過去)
  • 市場分析:各市場區隔(現在、未來)
    • 北美
    • 南美
    • 歐洲
    • 東亞
    • 南亞
    • 大洋洲
    • 中東、非洲
  • 市場魅力分析:各地區

第14章 北美的呼吸系統介入市場:分析與預測

  • 簡介
  • 市場分析:各市場區隔(過去)
  • 市場分析:各市場區隔(現在、未來)
    • 各國
    • 各產品
    • 各適應症
    • 各終端用戶
  • 市場魅力分析
  • 主要加入企業 - 市場集中度製圖
  • 推動要素及阻礙因素 - 影響分析

第15章 南美的呼吸系統介入市場:分析與預測

  • 簡介
  • 市場分析:各市場區隔(過去)
  • 市場分析:各市場區隔(現在、未來)
    • 各國
    • 各產品
    • 各適應症
    • 各終端用戶
  • 市場魅力分析
  • 主要加入企業 - 市場集中度製圖
  • 推動要素及阻礙因素 - 影響分析

第16章 歐洲的呼吸系統介入市場:分析與預測

  • 簡介
  • 市場分析:各市場區隔(過去)
  • 市場分析:各市場區隔(現在、未來)
    • 各國
    • 各產品
    • 各適應症
    • 各終端用戶
  • 市場魅力分析
  • 主要加入企業 - 市場集中度製圖
  • 推動要素及阻礙因素 - 影響分析

第17章 南亞的呼吸系統介入市場:分析與預測

  • 簡介
  • 市場分析:各市場區隔(過去)
  • 市場分析:各市場區隔(現在、未來)
    • 各國
    • 各產品
    • 各適應症
    • 各終端用戶
  • 市場魅力分析
  • 主要加入企業 - 市場集中度製圖
  • 推動要素及阻礙因素 - 影響分析

第18章 東亞的呼吸系統介入市場:分析與預測

  • 簡介
  • 市場分析:各市場區隔(過去)
  • 市場分析:各市場區隔(現在、未來)
    • 各國
    • 各產品
    • 各適應症
    • 各終端用戶
  • 市場魅力分析
  • 主要加入企業 - 市場集中度製圖
  • 推動要素及阻礙因素 - 影響分析

第19章 大洋洲的呼吸系統介入市場:分析與預測

  • 簡介
  • 市場分析:各市場區隔(過去)
  • 市場分析:各市場區隔(現在、未來)
    • 各國
    • 各產品
    • 各適應症
    • 各終端用戶
  • 市場魅力分析
  • 主要加入企業 - 市場集中度製圖
  • 推動要素及阻礙因素 - 影響分析

第20章 中東、非洲的呼吸系統介入市場:分析與預測

  • 簡介
  • 市場分析:各市場區隔(過去)
  • 市場分析:各市場區隔(現在、未來)
    • 各國
    • 各產品
    • 各適應症
    • 各終端用戶
  • 市場魅力分析
  • 主要加入企業 - 市場集中度製圖
  • 推動要素及阻礙因素 - 影響分析

第21章 呼吸系統介入市場分析:各主要國家

  • 美國的呼吸系統介入市場
    • 各產品
    • 各適應症
    • 各終端用戶
  • 加拿大的呼吸系統介入市場
    • 各產品
    • 各適應症
    • 各終端用戶
  • 巴西的呼吸系統介入市場
    • 各產品
    • 各適應症
    • 各終端用戶
  • 墨西哥的呼吸系統介入市場
    • 各產品
    • 各適應症
    • 各終端用戶
  • 阿根廷的呼吸系統介入市場
    • 各產品
    • 各適應症
    • 各終端用戶
  • 英國的呼吸系統介入市場
    • 各產品
    • 各適應症
    • 各終端用戶
  • 德國的呼吸系統介入市場
    • 各產品
    • 各適應症
    • 各終端用戶
  • 法國的呼吸系統介入市場
    • 各產品
    • 各適應症
    • 各終端用戶
  • 義大利的呼吸系統介入市場
    • 各產品
    • 各適應症
    • 各終端用戶
  • 西班牙的呼吸系統介入市場
    • 各產品
    • 各適應症
    • 各終端用戶
  • 荷比盧三國的呼吸系統介入市場
    • 各產品
    • 各適應症
    • 各終端用戶
  • 俄羅斯的呼吸系統介入市場
    • 各產品
    • 各適應症
    • 各終端用戶
  • 日本的呼吸系統介入市場
    • 各產品
    • 各適應症
    • 各終端用戶
  • 中國的呼吸系統介入市場
    • 各產品
    • 各適應症
    • 各終端用戶
  • 韓國的呼吸系統介入市場
    • 各產品
    • 各適應症
    • 各終端用戶
  • 印度的呼吸系統介入市場
    • 各產品
    • 各適應症
    • 各終端用戶
  • ASEAN的呼吸系統介入市場
    • 各產品
    • 各適應症
    • 各終端用戶
  • 澳洲的呼吸系統介入市場
    • 各產品
    • 各適應症
    • 各終端用戶
  • 紐西蘭的呼吸系統介入市場
    • 各產品
    • 各適應症
    • 各終端用戶
  • 波灣合作理事會(GCC)的呼吸系統介入市場
    • 各產品
    • 各適應症
    • 各終端用戶
  • 土耳其的呼吸系統介入市場
    • 各產品
    • 各適應症
    • 各終端用戶
  • 南非的呼吸系統介入市場
    • 各產品
    • 各適應症
    • 各終端用戶

第22章 市場結構分析

  • 市場分析: 各企業等級
  • 市場集中度
  • 主要企業的市場佔有率分析
  • 市場影響分析

第23章 競爭分析

  • 競爭儀表板
  • 競爭情形
    • Medtronic Plc
    • Boston Scientific Corporation
    • Olympus Corporation
    • FUJIFILM Corporation
    • Becton, Dickinson and Company
    • Smiths Group Plc
    • Cook Medical
    • Vygon
    • Clarus Medical LLC
    • Huger Medical Instrument Co. Ltd
    • Taewoong Medical Co. Ltd.
    • Shanghai AoHua Photoelectricity Endoscope Co., Ltd
    • Karl Storz
    • Richard Wolf Corporation
    • PENTAX Medical

第24章 假設和縮寫

第25章 調查手法

目錄
Product Code: PMRREP12544

Interventional Pulmonology Market - Scope of Report

Persistence Market Research recently published a market study on the global market for interventional pulmonology. The study provides detailed assessment on key market dynamics, including the drivers, trends, opportunities, restraints, and detailed information about the market structure. The market study presents exclusive information about how the interventional pulmonology market will grow during the forecast period of 2021-2031.

Key indicators of market growth, which include Year-on-Year (Y-o-Y) growth of the market, and compounded annual growth rate (CAGR) are explained in Persistence Market Research's study in a comprehensive manner. This information can help readers understand the quantitative growth prospects of the market during the forecast period.

The study is relevant for stakeholders in the interventional pulmonology market, including product manufacturers, suppliers, distributors, and investors, and can help them in developing appropriate strategies to grow in this space. Stakeholders in the interventional pulmonology market, investors, industry experts, researchers, and journalists, as well as business researchers can leverage the information and data presented in the study.

The study also includes statistics as well as facts related to the macro- as well as micro-economic factors that are impacting developments in the market. It also offers actionable insights based on the future trends in the market. Furthermore, small businesses and new entrants in the market too can make use of the information presented in this study, based on which, they can make appropriate business decisions to gain momentum in the market.

Key Segments of Market

Persistence Market Research's study on the interventional pulmonology market offers information divided into four important segments - product, indication, end user, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

Product

Electromagnetic Navigation Bronchoscopy (ENB)

IP Diagnostic Devices

Bronchoscopes

Flexible Bronchoscope

Rigid bronchoscope

EBUS

Aspiration Needles

Biopsy Foreceps

Pleuroscopes

Semi-flexible Pleuroscopes

Rigid Pleuroscopes

Others

IP Therapeutic Devices

Airway Stents

Endobronchial Ablation Systems

Pleural Drainage Catheters

Endobronchial Valves

Indication

Asthma

Lung Cancer

COPD

Foreign Body Extraction

Tracheal and Bronchial Stenosis

End User

Hospitals

Pulmonology Clinics

Ambulatory Surgical Centers

Diagnostic Centers

Region

Global

China

U.S.

Europe

Key Questions Answered in Report

Which regions will continue to remain the most profitable regional markets for interventional pulmonology?

Which factors will induce a change in the demand for interventional pulmonology during the assessment period?

How will changing trends impact the interventional pulmonology market?

How can market players capture the low-hanging opportunities in developed regions?

Which companies are leading the interventional pulmonology market?

What are the winning strategies of stakeholders in the market to upscale their position in this landscape?

Research Methodology

In Persistence Market Research's study, a unique research methodology is utilized to conduct extensive research on the growth of the interventional pulmonology market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure the accuracy and reliability of the conclusions.

Secondary resources referred to by analysts during the production of the market study include statistics from government organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.

Comprehensive information acquired from primary and secondary resources acts as a validation from companies in the interventional pulmonology market, and makes Persistence Market Research's projections on the growth prospects of the market more accurate and reliable.

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusion and Exclusions

3. Key Market Trends

4. Key Success Factors

  • 4.1. Value Chain Analysis
  • 4.2. Regulatory Scenario
  • 4.3. Tracheal and Bronchial Stenosis Procedures, By Key Regions
  • 4.4. Key Interventional Pulmonology Procedure Statistics, By key Region

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global GDP Growth Outlook
    • 5.1.2. Global Healthcare Spending
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. Increasing prevalence of Respiratory Diseases
    • 5.2.2. Cost of Treatment
    • 5.2.3. Government Funding to Support Healthcare
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Trends
    • 5.3.4. Opportunity Analysis

6. COVID19 Crisis Analysis

  • 6.1. Current COVID19 Statistics and Probable Future Impact
  • 6.2. Current GDP Projection and Probable Impact
  • 6.3. Current Economic Projection as compared to 2008 Economic analysis
  • 6.4. COVID19 and Impact Analysis
    • 6.4.1. Revenue by Product
    • 6.4.2. Revenue by Indication
    • 6.4.3. Revenue by End User
    • 6.4.4. Revenue By Country
  • 6.5. Industrial Outlook
  • 6.6. Economic Impact
  • 6.7. COVID19 Crisis Analysis Probable Future Impact

7. Global Interventional Pulmonology Market Volume (Units) Analysis 2016-2020 and Forecast, 2021-2031

  • 7.1. Historical Market Volume (Units) Analysis, 2016-2020
  • 7.2. Current and Future Market Volume (Units) Projections, 2021-2031
    • 7.2.1. Y-o-Y Growth Trend Analysis

8. Global Interventional Pulmonology Market- Pricing Analysis

  • 8.1. Regional Pricing Analysis By Product
  • 8.2. Pricing Break-up
    • 8.2.1. Manufacturer Level Pricing
    • 8.2.2. Distributor Level Pricing
  • 8.3. Global Average Pricing Analysis Benchmark

9. Global Interventional Pulmonology Market Value (US$ Mn) Analysis 2016-2020 and Forecast, 2021-2031

  • 9.1. Historical Market Value (US$ Mn) Analysis, 2016-2020
  • 9.2. Current and Future Market Value (US$ Mn) Projections, 2021-2031
    • 9.2.1. Y-o-Y Growth Trend Analysis
    • 9.2.2. Absolute $ Opportunity Analysis

10. Global Interventional Pulmonology Market Analysis 2016-2020 and Forecast 2021-2031, By Product

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Mn) By Product, 2016-2020
  • 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product, 2021-2031
    • 10.3.1. Electromagnetic Navigation Bronchoscopy (ENB)
    • 10.3.2. IP Diagnostic Devices
      • 10.3.2.1. Bronchoscopes
        • 10.3.2.1.1. Flexible Bronchoscope
        • 10.3.2.1.2. Rigid bronchoscope
      • 10.3.2.2. EBUS
      • 10.3.2.3. Aspiration Needles
      • 10.3.2.4. Biopsy Foreceps
      • 10.3.2.5. Pleuroscopes
        • 10.3.2.5.1. Semi-flexible Pleuroscopes
        • 10.3.2.5.2. Rigid Pleuroscopes
      • 10.3.2.6. Others
    • 10.3.3. IP therapeutic devices
      • 10.3.3.1. Airway Stents
      • 10.3.3.2. Endobronchial Ablation Systems
      • 10.3.3.3. Pleural drainage catheters
      • 10.3.3.4. Endobronchial Valves
  • 10.4. Market Attractiveness Analysis By Product

11. Global Interventional Pulmonology Market Analysis 2016-2020 and Forecast 2021-2031, By Indication

  • 11.1. Introduction / Key Findings
  • 11.2. Historical Market Size (US$ Mn) By Availability, 2016-2020
  • 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Indication, 2021-2031
    • 11.3.1. Asthma
    • 11.3.2. Lung Cancer
    • 11.3.3. COPD
    • 11.3.4. Foreign Body Extraction
    • 11.3.5. Tracheal and Bronchial Stenosis
  • 11.4. Market Attractiveness Analysis By Indication

12. Global Interventional Pulmonology Market Analysis 2016-2020 and Forecast 2021-2031, By End User

  • 12.1. Introduction / Key Findings
  • 12.2. Historical Market Size (US$ Mn) By End User , 2016-2020
  • 12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User , 2021-2031
    • 12.3.1. Hospitals
    • 12.3.2. Pulmonology Clinics
    • 12.3.3. Ambulatory Surgical Centers
    • 12.3.4. Diagnostic Centers
  • 12.4. Market Attractiveness Analysis By End User

13. Global Interventional Pulmonology Market Analysis 2016-2020 and Forecast 2021-2031, by Region

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Mn) Analysis By Region, 2015 - 2020
  • 13.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2020 - 2030
    • 13.3.1. North America
    • 13.3.2. Latin America
    • 13.3.3. Europe
    • 13.3.4. East Asia
    • 13.3.5. South Asia
    • 13.3.6. Oceania
    • 13.3.7. Middle East and Africa (MEA)
  • 13.4. Market Attractiveness Analysis By Region

14. North America Interventional Pulmonology Market Analysis 2016-2020 and Forecast 2021-2031

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2016-2020
  • 14.3. Current and Future Market Size (US$ Mn) Analysis Forecast By Market Taxonomy, 2021-2031
    • 14.3.1. By Country
      • 14.3.1.1. U.S.
      • 14.3.1.2. Canada
    • 14.3.2. By Product
    • 14.3.3. By Indication
    • 14.3.4. By End User
  • 14.4. Market Attractiveness Analysis
  • 14.5. Key Market Participants - Intensity Mapping
  • 14.6. Drivers and Restraints - Impact Analysis

15. Latin America Interventional Pulmonology Market Analysis 2016-2020 and Forecast 2021-2031

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014 - 2018
  • 15.3. Current and Future Market Size (US$ Mn) Analysis Forecast By Market Taxonomy, 2021-2031
    • 15.3.1. By Country
      • 15.3.1.1. Brazil
      • 15.3.1.2. Mexico
      • 15.3.1.3. Argentina
      • 15.3.1.4. Rest of Latin America
    • 15.3.2. By Product
    • 15.3.3. By Indication
    • 15.3.4. By End User
  • 15.4. Market Attractiveness Analysis
  • 15.5. Key Market Participants - Intensity Mapping
  • 15.6. Drivers and Restraints - Impact Analysis

16. Europe Interventional Pulmonology Market Analysis 2016-2020 and Forecast 2021-2031

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2016-2020
  • 16.3. Current and Future Market Size (US$ Mn) Analysis Forecast By Market Taxonomy 2021-2031
    • 16.3.1. By Country
      • 16.3.1.1. Germany
      • 16.3.1.2. Italy
      • 16.3.1.3. France
      • 16.3.1.4. U.K.
      • 16.3.1.5. Spain
      • 16.3.1.6. BENELUX
      • 16.3.1.7. Russia
      • 16.3.1.8. Rest of Europe
    • 16.3.1. By Product
    • 16.3.2. By Indication
    • 16.3.3. By End User
  • 16.4. Market Attractiveness Analysis
  • 16.5. Key Market Participants - Intensity Mapping
  • 16.6. Drivers and Restraints - Impact Analysis

17. South Asia Interventional Pulmonology Market Analysis 2016-2020 and Forecast 2021-2031

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2016-2020
  • 17.3. Current and Future Market Size (US$ Mn) Analysis By Market Taxonomy2021-2031
    • 17.3.1. By Country
      • 17.3.1.1. India
      • 17.3.1.2. Thailand
      • 17.3.1.3. Indonesia
      • 17.3.1.4. Malaysia
      • 17.3.1.5. Rest of South Asia
    • 17.3.1. By Product
    • 17.3.2. By Indication
    • 17.3.3. By End User
  • 17.4. Market Attractiveness Analysis
  • 17.5. Key Market Participants - Intensity Mapping
  • 17.6. Drivers and Restraints - Impact Analysis

18. East Asia Interventional Pulmonology Market Analysis 2016-2020 and Forecast 2021-2031

  • 18.1. Introduction
  • 18.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2016-2020
  • 18.3. Current and Future Market Size (US$ Mn) Analysis By Market Taxonomy, 2021-2031
    • 18.3.1. By Country
      • 18.3.1.1. China
      • 18.3.1.2. Japan
      • 18.3.1.3. South Korea
    • 18.3.1. By Product
    • 18.3.2. By Indication
    • 18.3.3. By End User
  • 18.4. Market Attractiveness Analysis
  • 18.5. Key Market Participants - Intensity Mapping
  • 18.6. Drivers and Restraints - Impact Analysis

19. Oceania Interventional Pulmonology Market Analysis 2016-2020 and Forecast 2021-2031

  • 19.1. Introduction
  • 19.2. Historical Market Size (US$ Mn Analysis By Market Taxonomy, 2016-2020
  • 19.3. Current and Future Market Size (US$ Mn) Analysis By Market Taxonomy, 2021-2031
    • 19.3.1. By Country
      • 19.3.1.1. Australia
      • 19.3.1.2. New Zealand
    • 19.3.1. By Product
    • 19.3.2. By Indication
    • 19.3.3. By End User
  • 19.4. Market Attractiveness Analysis
  • 19.5. Key Market Participants - Intensity Mapping
  • 19.6. Drivers and Restraints - Impact Analysis

20. Middle East and Africa Interventional Pulmonology Market Analysis 2016-2020 and Forecast 2021-2031

  • 20.1. Introduction
  • 20.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2016-2020
  • 20.3. Current and Future Market Size (US$ Mn) Analysis By Market Taxonomy, 2021-2031
    • 20.3.1. By Country
      • 20.3.1.1. GCC Countries
      • 20.3.1.2. Turkey
      • 20.3.1.3. South Africa
      • 20.3.1.4. Rest of Middle East and Africa
    • 20.3.2. By Product
    • 20.3.3. By Indication
    • 20.3.4. By End User
  • 20.4. Market Attractiveness Analysis
  • 20.5. Key Market Participants - Intensity Mapping
  • 20.6. Drivers and Restraints - Impact Analysis

21. Key Countries Interventional Pulmonology Market Analysis 2016-2020 and Forecast 2021-2031

  • 21.1. U.S. Interventional Pulmonology Market Analysis
    • 21.1.1. By Product
    • 21.1.1. By Indication
    • 21.1.2. By End User
  • 21.2. Canada Interventional Pulmonology Market Analysis
    • 21.2.1. By Product
    • 21.2.1. By Indication
    • 21.2.2. By End User
  • 21.3. Brazil Interventional Pulmonology Market Analysis
    • 21.3.1. By Product
    • 21.3.1. By Indication
    • 21.3.2. By End User
  • 21.4. Mexico Interventional Pulmonology Market Analysis
    • 21.4.1. By Product
    • 21.4.1. By Indication
    • 21.4.2. By End User
  • 21.5. Argentina Interventional Pulmonology Market Analysis
    • 21.5.1. By Product
    • 21.5.1. By Indication
    • 21.5.2. By End User
  • 21.6. U.K. Interventional Pulmonology Market Analysis
    • 21.6.1. By Product
    • 21.6.1. By Indication
    • 21.6.2. By End User
  • 21.7. Germany Interventional Pulmonology Market Analysis
    • 21.7.1. By Product
    • 21.7.1. By Indication
    • 21.7.2. By End User
  • 21.8. France Interventional Pulmonology Market Analysis
    • 21.8.1. By Product
    • 21.8.1. By Indication
    • 21.8.2. By End User
  • 21.9. Italy Interventional Pulmonology Market Analysis
    • 21.9.1. By Product
    • 21.9.1. By Indication
    • 21.9.2. By End User
  • 21.10. Spain Interventional Pulmonology Market Analysis
    • 21.10.1. By Product
    • 21.10.1. By Indication
    • 21.10.2. By End User
  • 21.11. BENELUX Interventional Pulmonology Market Analysis
    • 21.11.1. By Product
    • 21.11.1. By Indication
    • 21.11.2. By End User
  • 21.12. Russia Interventional Pulmonology Market Analysis
    • 21.12.1. By Product
    • 21.12.1. By Indication
    • 21.12.2. By End User
  • 21.13. Japan Interventional Pulmonology Market Analysis
    • 21.13.1. By Product
    • 21.13.1. By Indication
    • 21.13.2. By End User
  • 21.14. China Interventional Pulmonology Market Analysis
    • 21.14.1. By Product
    • 21.14.1. By Indication
    • 21.14.2. By End User
  • 21.15. South Korea Interventional Pulmonology Market Analysis
    • 21.15.1. By Product
    • 21.15.1. By Indication
    • 21.15.2. By End User
  • 21.16. India Interventional Pulmonology Market Analysis
    • 21.16.1. By Product
    • 21.16.1. By Indication
    • 21.16.2. By End User
  • 21.17. ASEAN Interventional Pulmonology Market Analysis
    • 21.17.1. By Product
    • 21.17.1. By Indication
    • 21.17.2. By End User
  • 21.18. Australia Interventional Pulmonology Market Analysis
    • 21.18.1. By Product
    • 21.18.1. By Indication
    • 21.18.2. By End User
  • 21.19. New Zealand Interventional Pulmonology Market Analysis
    • 21.19.1. By Product
    • 21.19.1. By Indication
    • 21.19.2. By End User
  • 21.20. GCC Countries Interventional Pulmonology Market Analysis
    • 21.20.1. By Product
    • 21.20.1. By Indication
    • 21.20.2. By End User
  • 21.21. Turkey Interventional Pulmonology Market Analysis
    • 21.21.1. By Product
    • 21.21.1. By Indication
    • 21.21.2. By End User
  • 21.22. South Africa Interventional Pulmonology Market Analysis
    • 21.22.1. By Product
    • 21.22.1. By Indication
    • 21.22.2. By End User

22. Market Structure Analysis

  • 22.1. Market Analysis by Tier of Companies
  • 22.2. Market Concentration
  • 22.3. Market Share Analysis of Top Players
  • 22.4. Market Presence Analysis
      • 22.4.1.1. Regional footprint of Players
      • 22.4.1.2. Method foot print by Players
      • 22.4.1.3. Channel Foot Print by Players

23. Competition Analysis

  • 23.1. Competition Dashboard
  • 23.2. Competition Deep Dive
    • 23.2.1. Medtronic Plc
      • 23.2.1.1. Overview
      • 23.2.1.2. Product Portfolio
      • 23.2.1.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.2.1.4. Sales Footprint
      • 23.2.1.5. Strategy Overview
        • 23.2.1.5.1. Marketing Strategy
        • 23.2.1.5.2. Product Strategy
        • 23.2.1.5.3. Channel Strategy
    • 23.2.2. Boston Scientific Corporation
      • 23.2.2.1. Overview
      • 23.2.2.2. Product Portfolio
      • 23.2.2.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.2.2.4. Sales Footprint
      • 23.2.2.5. Strategy Overview
        • 23.2.2.5.1. Marketing Strategy
        • 23.2.2.5.2. Product Strategy
        • 23.2.2.5.3. Channel Strategy
    • 23.2.3. Olympus Corporation
      • 23.2.3.1. Overview
      • 23.2.3.2. Product Portfolio
      • 23.2.3.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.2.3.4. Sales Footprint
      • 23.2.3.5. Strategy Overview
        • 23.2.3.5.1. Marketing Strategy
        • 23.2.3.5.2. Product Strategy
        • 23.2.3.5.3. Channel Strategy
    • 23.2.4. FUJIFILM Corporation
      • 23.2.4.1. Overview
      • 23.2.4.2. Product Portfolio
      • 23.2.4.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.2.4.4. Sales Footprint
      • 23.2.4.5. Strategy Overview
        • 23.2.4.5.1. Marketing Strategy
        • 23.2.4.5.2. Product Strategy
        • 23.2.4.5.3. Channel Strategy
    • 23.2.5. Becton, Dickinson and Company
      • 23.2.5.1. Overview
      • 23.2.5.2. Product Portfolio
      • 23.2.5.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.2.5.4. Sales Footprint
      • 23.2.5.5. Strategy Overview
        • 23.2.5.5.1. Marketing Strategy
        • 23.2.5.5.2. Product Strategy
        • 23.2.5.5.3. Channel Strategy
    • 23.2.6. Smiths Group Plc
      • 23.2.6.1. Overview
      • 23.2.6.2. Product Portfolio
      • 23.2.6.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.2.6.4. Sales Footprint
      • 23.2.6.5. Strategy Overview
        • 23.2.6.5.1. Marketing Strategy
        • 23.2.6.5.2. Product Strategy
        • 23.2.6.5.3. Channel Strategy
    • 23.2.7. Cook Medical
      • 23.2.7.1. Overview
      • 23.2.7.2. Product Portfolio
      • 23.2.7.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.2.7.4. Sales Footprint
      • 23.2.7.5. Strategy Overview
        • 23.2.7.5.1. Marketing Strategy
        • 23.2.7.5.2. Product Strategy
        • 23.2.7.5.3. Channel Strategy
    • 23.2.8. Vygon
      • 23.2.8.1. Overview
      • 23.2.8.2. Product Portfolio
      • 23.2.8.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.2.8.4. Sales Footprint
      • 23.2.8.5. Strategy Overview
        • 23.2.8.5.1. Marketing Strategy
        • 23.2.8.5.2. Product Strategy
        • 23.2.8.5.3. Channel Strategy
    • 23.2.9. Clarus Medical LLC
      • 23.2.9.1. Overview
      • 23.2.9.2. Product Portfolio
      • 23.2.9.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.2.9.4. Sales Footprint
      • 23.2.9.5. Strategy Overview
        • 23.2.9.5.1. Marketing Strategy
        • 23.2.9.5.2. Product Strategy
        • 23.2.9.5.3. Channel Strategy
    • 23.2.10. Huger Medical Instrument Co. Ltd
      • 23.2.10.1. Overview
      • 23.2.10.2. Product Portfolio
      • 23.2.10.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.2.10.4. Sales Footprint
      • 23.2.10.5. Strategy Overview
        • 23.2.10.5.1. Marketing Strategy
        • 23.2.10.5.2. Product Strategy
        • 23.2.10.5.3. Channel Strategy
    • 23.2.11. Taewoong Medical Co. Ltd.
      • 23.2.11.1. Overview
      • 23.2.11.2. Product Portfolio
      • 23.2.11.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.2.11.4. Sales Footprint
      • 23.2.11.5. Strategy Overview
        • 23.2.11.5.1. Marketing Strategy
        • 23.2.11.5.2. Product Strategy
        • 23.2.11.5.3. Channel Strategy
    • 23.2.12. Shanghai AoHua Photoelectricity Endoscope Co., Ltd
      • 23.2.12.1. Overview
      • 23.2.12.2. Product Portfolio
      • 23.2.12.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.2.12.4. Sales Footprint
      • 23.2.12.5. Strategy Overview
        • 23.2.12.5.1. Marketing Strategy
        • 23.2.12.5.2. Product Strategy
        • 23.2.12.5.3. Channel Strategy
    • 23.2.13. Karl Storz
      • 23.2.13.1. Overview
      • 23.2.13.2. Product Portfolio
      • 23.2.13.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.2.13.4. Sales Footprint
      • 23.2.13.5. Strategy Overview
        • 23.2.13.5.1. Marketing Strategy
        • 23.2.13.5.2. Product Strategy
        • 23.2.13.5.3. Channel Strategy
    • 23.2.14. Richard Wolf Corporation
      • 23.2.14.1. Overview
      • 23.2.14.2. Product Portfolio
      • 23.2.14.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.2.14.4. Sales Footprint
      • 23.2.14.5. Strategy Overview
        • 23.2.14.5.1. Marketing Strategy
        • 23.2.14.5.2. Product Strategy
        • 23.2.14.5.3. Channel Strategy
    • 23.2.15. PENTAX Medical
      • 23.2.15.1. Overview
      • 23.2.15.2. Product Portfolio
      • 23.2.15.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.2.15.4. Sales Footprint
      • 23.2.15.5. Strategy Overview
        • 23.2.15.5.1. Marketing Strategy
        • 23.2.15.5.2. Product Strategy
        • 23.2.15.5.3. Channel Strategy

24. Assumptions and Acronyms Used

25. Research Methodology

List of Tables

  • Table 01: Global Interventional Pulmonology Market Volume (in '000 Unit) Analysis 2016-2020 and Forecast 2021-2031, By Region
  • Table 02: Global Interventional Pulmonology Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product (1/2)
  • Table 03: Global Interventional Pulmonology Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product (2/2)
  • Table 04: Global Interventional Pulmonology Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by Indication
  • Table 05: Global Interventional Pulmonology Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by End User
  • Table 06: Global Interventional Pulmonology Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Region
  • Table 07: U.S. Interventional Pulmonology Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product (1/2)
  • Table 08: U.S. Interventional Pulmonology Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product (2/2)
  • Table 09: U.S. Interventional Pulmonology Market Volume (in '000 Units) Analysis 2016-2020 and Forecast 2021-2031, By Product (1/2)
  • Table 10: U.S. Interventional Pulmonology Market Volume (in '000 Units) Analysis 2016-2020 and Forecast 2021-2031, By Product (2/2)
  • Table 11: U.S. Interventional Pulmonology Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by Indication
  • Table 12: U.S. Interventional Pulmonology Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by End User
  • Table 13: China Interventional Pulmonology Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product (1/2)
  • Table 14: China Interventional Pulmonology Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product (2/2)
  • Table 15: China Interventional Pulmonology Market Volume (in '000 Units) Analysis 2016-2020 and Forecast 2021-2031, By Product (1/2)
  • Table 16: China Interventional Pulmonology Market Volume (in '000 Units) Analysis 2016-2020 and Forecast 2021-2031, By Product (2/2)
  • Table 17: China Interventional Pulmonology Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by Indication
  • Table 18: China Interventional Pulmonology Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by End User
  • Table 19: Europe Interventional Pulmonology Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product (1/2)
  • Table 20: Europe Interventional Pulmonology Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product (2/2)
  • Table 21: ROW Interventional Pulmonology Market Volume (in '000 Units) Analysis 2016-2020 and Forecast 2021-2031, By Product (1/2)
  • Table 22: ROW Interventional Pulmonology Market Volume (in '000 Units) Analysis 2016-2020 and Forecast 2021-2031, By Product (2/2)
  • Table 23: Europe Interventional Pulmonology Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by Indication
  • Table 24: Europe Interventional Pulmonology Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by End User
  • Table 25: Europe Interventional Pulmonology Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country
  • Table 26: ROW Interventional Pulmonology Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product (1/2)
  • Table 27: ROW Interventional Pulmonology Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product (2/2)
  • Table 28: ROW Interventional Pulmonology Market Volume (in '000 Units) Analysis 2016-2020 and Forecast 2021-2031, By Product(1/2)
  • Table 29: ROW Interventional Pulmonology Market Volume (in '000 Units) Analysis 2016-2020 and Forecast 2021-2031, By Product (2/2)
  • Table 30: ROW Interventional Pulmonology Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by Indication
  • Table 31: ROW Interventional Pulmonology Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by End User

List of Figures

  • Figure 01: Global Interventional Pulmonology Market Share, By Product (2020)
  • Figure 02: Global Interventional Pulmonology Market Share, By Indication (2020)
  • Figure 03: Global Interventional Pulmonology Market Share, By End User (2020)
  • Figure 04: Global Interventional Pulmonology Market Share, By Region (2020)
  • Figure 05: Global Interventional Pulmonology Market Volume (in '000 Unit) Analysis, 2016-2020
  • Figure 06: Global Interventional Pulmonology Market Volume (in '000 Unit) & Y-o-Y Growth (%) Analysis, 2021-2031
  • Figure 07: Global Interventional Pulmonology(ENB, EBUS and Endobronchial Ablation Systems) ,Price Difference (US$) By Region, 2020
  • Figure 08: Global Interventional Pulmonology(ENB, EBUS and Endobronchial Ablation Systems) ,Price Difference (US$) By Region, 2031
  • Figure 09: Global Interventional Pulmonology Market Attractiveness Analysis 2021-2031, by Indication
  • Figure 10: Global Interventional Pulmonology(Semi-flexible Pleuroscopes and Rigid Pleuroscopes) , Price Difference (US$) By Region, 2031
  • Figure 11: Global Interventional Pulmonology(Flexible Bronchoscope, Rigid bronchoscope) , Price Difference (US$) By Region, 2020
  • Figure 12: Global Interventional Pulmonology(Flexible Bronchoscope, Rigid bronchoscope) , Price Difference (US$) By Region, 2031
  • Figure 13: Global Interventional Pulmonology(Aspiration Needles, Biopsy Forceps, Others) ,Price Difference (US$) By Region, 2020
  • Figure 14: Global Interventional Pulmonology(Aspiration Needles, Biopsy Forceps, Others) , Price Difference (US$) By Region, 2031
  • Figure 15: Global Interventional Pulmonology(Airway Stents, Pleural drainage catheters, Endobronchial Valves) , Price Difference (US$) By Region, 2020
  • Figure 16: Global Interventional Pulmonology(Airway Stents, Pleural drainage catheters, Endobronchial Valves) , Price Difference (US$) By Region, 2031
  • Figure 17: Global Interventional Pulmonology Market Size (US$ Mn) Analysis, 2016-2020
  • Figure 18: Global Interventional Pulmonology Market Size (US$ Mn) & Y-o-Y Growth (%) Analysis, 2021-2031
  • Figure 19: Global Interventional Pulmonology Market Absolute $ Opportunity Analysis, 2021-2031
  • Figure 20: Global Interventional Pulmonology Market Analysis by Product-2021 & 2031
  • Figure 21: Global Interventional Pulmonology Market Y-o-Y Growth Projections by Product, 2021 - 2031
  • Figure 22: Global Interventional Pulmonology Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by Product
  • Figure 23: Global Interventional Pulmonology Market Analysis by Indication -2021 & 2031
  • Figure 24: Global Interventional Pulmonology Market Y-o-Y Growth Projections by Indication , 2021 - 2031
  • Figure 25: Global Interventional Pulmonology Market Analysis by End User-2021 & 2031
  • Figure 26: Global Interventional Pulmonology Market Y-o-Y Growth Projections by End User, 2021 - 2031
  • Figure 27: Global Interventional Pulmonology Market Attractiveness Analysis 2021-2031, by End User
  • Figure 28: Global Interventional Pulmonology Market Analysis by Region-2021 & 2031
  • Figure 29: Global Interventional Pulmonology Market Y-o-Y Growth Projections by Region, 2021 - 2031
  • Figure 30: Global Interventional Pulmonology Market Attractiveness Analysis 2021-2031, By Region
  • Figure 31: U.S. Interventional Pulmonology Market Share, By Product, 2021 (E)
  • Figure 32: U.S. Interventional Pulmonology Market Share, By Indication, 2021 (E)
  • Figure 33: U.S. Interventional Pulmonology Market Share, By End User, 2021 (E)
  • Figure 34: U.S. Interventional Pulmonology Market Size (US$ Mn) Analysis, 2016-2020
  • Figure 35: U.S. Interventional Pulmonology Market Size (US$ Mn) & Y-o-Y Growth (%), 2021-2031
  • Figure 36: U.S. Interventional Pulmonology Market Attractiveness Analysis By Product, 2021-2031
  • Figure 37: U.S. Interventional Pulmonology Market Attractiveness Analysis By Indication, 2021-2031
  • Figure 38: U.S. Interventional Pulmonology Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by End User
  • Figure 39: China Interventional Pulmonology Market Share, By Product, 2021 (E)
  • Figure 40: China Interventional Pulmonology Market Share, By Indication, 2021 (E)
  • Figure 41: China Interventional Pulmonology Market Share, By End User, 2021 (E)
  • Figure 42: China Interventional Pulmonology Market Size (US$ Mn) Analysis, 2016-2020
  • Figure 43: China Interventional Pulmonology Market Size (US$ Mn) & Y-o-Y Growth (%), 2021-2031
  • Figure 44: China Interventional Pulmonology Market Attractiveness Analysis By Product, 2021-2031
  • Figure 45: China Interventional Pulmonology Market Attractiveness Analysis By Indication, 2021-2031
  • Figure 46: China Interventional Pulmonology Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by End User
  • Figure 47: Europe Interventional Pulmonology Market Share, By Product, 2021 (E)
  • Figure 48: Europe Interventional Pulmonology Market Share, By Indication, 2021 (E)
  • Figure 49: Europe Interventional Pulmonology Market Share, By End User, 2021 (E)
  • Figure 50: Europe Interventional Pulmonology Market Size (US$ Mn) Analysis, 2016-2020
  • Figure 51: Europe Interventional Pulmonology Market Size (US$ Mn) & Y-o-Y Growth (%), 2021-2031
  • Figure 52: Europe Interventional Pulmonology Market Attractiveness Analysis By Product, 2021-2031
  • Figure 53: Europe Interventional Pulmonology Market Attractiveness Analysis By Indication, 2021-2031
  • Figure 54: Europe Interventional Pulmonology Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by End User
  • Figure 55: Europe Interventional Pulmonology Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by Country
  • Figure 56: ROW Interventional Pulmonology Market Share, By Product, 2021 (E)
  • Figure 57: ROW Interventional Pulmonology Market Share, By Indication, 2021 (E)
  • Figure 58: ROW Interventional Pulmonology Market Share, By End User, 2021 (E)
  • Figure 59: ROW Interventional Pulmonology Market Size (US$ Mn) Analysis, 2016-2020
  • Figure 60: ROW Interventional Pulmonology Market Size (US$ Mn) & Y-o-Y Growth (%), 2021-2031
  • Figure 61: ROW Interventional Pulmonology Market Attractiveness Analysis By Product, 2021-2031
  • Figure 62: ROW Interventional Pulmonology Market Attractiveness Analysis By Indication, 2021-2031
  • Figure 63: ROW Interventional Pulmonology Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by End User
  • Figure 64: Germany Market Value Proportion Analysis
  • Figure 65: Germany Interventional Pulmonology Market Share, By Product, 2021 & 2031
  • Figure 66: Germany Interventional Pulmonology Market Share, By Indication, 2021 & 2031
  • Figure 67: Germany Interventional Pulmonology Market Share, By End User, 2021 & 2031
  • Figure 68: U.K. Market Value Proportion Analysis
  • Figure 69: U.K. Interventional Pulmonology Market Share, By Product, 2021 & 2031
  • Figure 70: U.K. Interventional Pulmonology Market Share, By Indication, 2021 & 2031
  • Figure 71: U.K. Interventional Pulmonology Market Share, By End User, 2021 & 2031
  • Figure 72: France Market Value Proportion Analysis
  • Figure 73: France Interventional Pulmonology Market Share, By Product, 2021 & 2031
  • Figure 74: France Interventional Pulmonology Market Share, By Indication, 2021 & 2031
  • Figure 75: France Interventional Pulmonology Market Share, By End User, 2021 & 2031
  • Figure 76: Italy Market Value Proportion Analysis
  • Figure 77: Italy Interventional Pulmonology Market Share, By Product, 2021 & 2031
  • Figure 78: Italy Interventional Pulmonology Market Share, By Indication, 2021 & 2031
  • Figure 79: Italy Interventional Pulmonology Market Share, By End User, 2021 & 2031
  • Figure 80: Spain Market Value Proportion Analysis
  • Figure 81: Spain Interventional Pulmonology Market Share, By Product, 2021 & 2031
  • Figure 82: Spain Interventional Pulmonology Market Share, By Indication, 2021 & 2031
  • Figure 83: Spain Interventional Pulmonology Market Share, By End User, 2021 & 2031
  • Figure 84: Russia Market Value Proportion Analysis
  • Figure 85: Russia Interventional Pulmonology Market Share, By Product, 2021 & 2031
  • Figure 86: Russia Interventional Pulmonology Market Share, By Indication, 2021 & 2031
  • Figure 87: Russia Interventional Pulmonology Market Share, By End User, 2021 & 2031
  • Figure 88: BENELUX Market Value Proportion Analysis
  • Figure 89: BENELUX Interventional Pulmonology Market Share, By Product, 2021 & 2031
  • Figure 90: BENELUX Interventional Pulmonology Market Share, By Indication, 2021 & 2031
  • Figure 91: BENELUX Interventional Pulmonology Market Share, By End User, 2021 & 2031